Caris Life Sciences

United States
Brookdale, South Carolina, United States, 75039

Company profile

Caris Life Sciences company profile

Caris Life Sciences develops molecular profiling and AI-driven technologies to support precision medicine in oncology. The company offers a comprehensive tumor profiling service known as Caris Molecular Intelligence, which analyzes DNA, RNA, and proteins to help oncologists identify potential treatment options. Caris also operates a platform called Caris CODEai that integrates molecular data with clinical outcomes to support research and drug development. Its services cater to biopharma partners, healthcare providers, and academic institutions aiming to improve cancer diagnostics and therapy selection. The company incorporates machine learning models to discover new biomarkers and therapeutic targets based on large-scale multi-omic data.

Business identity

Contact email
[email protected]
Phone number
+1 888 979 8669
Operating status
Active
Company type
For Profit
Employee range
1,001-5,000 employees
Revenue range
$10M-$100M
Founded
2008-01-01, Year

Headquarters

Postal code
75039
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$1.2B
Last funding
Private Equity / $168M / 2025-04-07
Last equity funding
Private Equity / $168M
Investors
23
Lead investors
5
Articles
350
Exited on
2025-06-18

Founders and investors

Lead investors

BraidwellCoatueHighland Capital Management, LP.OrbiMedSixth Street

Investors

CoatueFidelityPerceptive AdvisorsSilver LakeSixth Street